{{chembox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 444473742
| ImageFile=Metahexamide.svg
| ImageSize = 250
| IUPACName = 1-(3-amino-4-methylphenyl)sulfonyl-3-cyclohexylurea
| OtherNames =

| Section1 = {{Chembox Identifiers
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = T3U6F5D722
| CASNo_Ref = {{cascite|correct|??}}
| CASNo = 565-33-3
| PubChem = 11259
| SMILES = CC1=C(C=C(C=C1)S(=O)(=O)NC(=O)NC2CCCCC2)N
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 507419
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = 10785
| InChI = 1/C14H21N3O3S/c1-10-7-8-12(9-13(10)15)21(19,20)17-14(18)16-11-5-3-2-4-6-11/h7-9,11H,2-6,15H2,1H3,(H2,16,17,18)
| InChIKey = XXYTXQGCRQLRHA-UHFFFAOYAB
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI = 1S/C14H21N3O3S/c1-10-7-8-12(9-13(10)15)21(19,20)17-14(18)16-11-5-3-2-4-6-11/h7-9,11H,2-6,15H2,1H3,(H2,16,17,18)
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey = XXYTXQGCRQLRHA-UHFFFAOYSA-N
| RTECS = 
| MeSHName = 
| ChEBI = 
| KEGG_Ref = {{keggcite|changed|kegg}}
| KEGG = D07117
  }}

| Section2 = {{Chembox Properties
| Formula = C<sub>14</sub>H<sub>21</sub>N<sub>3</sub>O<sub>3</sub>S
| MolarMass = 311.4 g/mol
| Appearance =
| Density =
| MeltingPt =
| BoilingPt =
| Solubility =
  }}

| Section6 = {{Chembox Pharmacology
| ATCCode_prefix = A10
| ATCCode_suffix = BB10
}}

| Section7 = {{Chembox Hazards
| MainHazards =
| FlashPt =
| AutoignitionPt =
  }}
}}

'''Metahexamide''' ([[International Nonproprietary Name|INN]]) is an [[anti-diabetic drug]] from the group of [[sulfonylurea]]s. It is long-acting and belongs to the first-generation cyclohexyl-containing sulfonylureas. It was first described in 1959.<ref>{{cite journal |doi=10.1111/j.1749-6632.1959.tb44940.x |vauthors=Moss JM, Delawter D |title=Metahexamide in diabetes therapy |journal=Ann NY Acad Sci |volume=82 |issue= 2|pages=614â€“7 |date=September 1959 |pmid=14424617}}</ref>

==References==
{{Reflist}}

{{Oral hypoglycemics and insulin analogs}}
{{Ion channel modulators}}

[[Category:Potassium channel blockers]]
[[Category:Sulfonylureas]]

{{gastrointestinal-drug-stub}}